| Issuer Name: | Revance Therapeutics Inc. | State/Country: | CALIFORNIA | IPO: | 2014 | CIK: | 1388649 |
| Industry: | pharmaceuticals | Sector: | health care | Fiscal Year End: | NA | investors.revance.com | |
|
Period:2024-09-30
C: 114 / 99
S: 53.34 M / 43.29 M |
Period:2024-06-30
C: 89 / 83
S: 10.72 M / 12.73 M |
| Holding Shares: | 122.48 Mil (Pct:117.0% 3M:30.0% 1Yr:17.0%) | Institutions reported:? | 206/176 (Acq:55% Dis:27% Res:16% Sold out:20%) | SC 13g/13d:? | 3M:3(mktqtl:0.95) 6M:3(mktqtl:0.93) |
| Industry Quantile: | 89.0% (3M:19.0% 1Yr:2.0%) | Sector Quantile: | 88.0% (3M:20.0% 1Yr:2.0%) | Market Quantile: | 90.0% (3M:22.0% 1Yr:2.0%) |
| FIGI ID: | BBG001J2MJH8 |
(13F reporting period:2024-09-30 Data last updated 2024-11-30 06:14:28 -0600 US CDT
|
|
|
|
Notes: Data summarized from Form 13F/13G/13D reports filed to the SEC.
Data is updated daily between 5am and 7am CDT (except holidays).
Corrections were automatically applied to holding values where per share price obviously deviates from market median.
|
Period:2024-09-30
C: 14 / 15
S: 80.08 M / 83.32 M |
Period:2024-06-30
C: 11 / 5
S: 43.80 M / 52.94 M |
| Holding Shares: | - (Pct:-% 3M:-% 1Yr:-%) | Institutions reported:? | 24/23 (Acq:58% Dis:20% Res:20% Sold out:41%) | SC 13g/13d:? | NA |
| Industry Quantile: | -% (3M:-% 1Yr:-%) | Sector Quantile: | -% (3M:-% 1Yr:-%) | Market Quantile: | -% (3M:-% 1Yr:-%) |
| FIGI ID: | NA |
(13F reporting period:2024-09-30 Data last updated 2024-11-30 06:14:28 -0600 US CDT
|
|
Notes: Data summarized from Form 13F/13G/13D reports filed to the SEC.
Data is updated daily between 5am and 7am CDT (except holidays).
Corrections were automatically applied to holding values where per share price obviously deviates from market median.
Details of Holding Changes & Schedule 13G/D Filings
COMMON STOCK CSV download
| Filing Date | Institution | Operationa | Reporting Period(last) | Shares(last) | Reporting Period | Shares | Value$1000 USD | Holding Change%b | Portfolio%c |
|---|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | VIRTU FINANCIAL LLC | Acquire | 2024-09-30 | 23129 | 120000 | 100.0% | 0.02% | ||
| 2024-11-15 | JANE STREET GROUP, LLC | Acquire | 2024-06-30 | 163913 | 2024-09-30 | 658454 | 3417376 | 301.71% | 0.16% |
| 2024-11-15 | NATIONAL BANK OF CANADA /FI/ | Restatement | 2024-09-30 | 932 | 2024-09-30 | 932 | 4837 | 0.0% | 0.0% |
| 2024-11-15 | BARCLAYS PLC | Acquire | 2024-06-30 | 37340 | 2024-09-30 | 173355 | 900000 | 364.26% | 0.05% |
| 2024-11-14 | COMERICA BANK | Restatement | 2024-06-30 | 426 | 2024-09-30 | 426 | 2211 | 0.0% | 0.0% |
| 2024-11-14 | D. E. SHAW & CO., INC. | Acquire | 2024-06-30 | 137980 | 2024-09-30 | 1962205 | 10183844 | 1322.09% | 0.47% |
| 2024-11-14 | PROSHARE ADVISORS LLC | Acquire | 2024-06-30 | 18157 | 2024-09-30 | 63097 | 327474 | 247.51% | 0.37% |
| 2024-11-14 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Acquire | 2024-09-30 | 1050000 | 5449500 | 100.0% | 0.62% | ||
| 2024-11-14 | ADAR1 CAPITAL MANAGEMENT, LLC | Acquire | 2024-09-30 | 182166 | 945442 | 100.0% | 1.12% | ||
| 2024-11-14 | CITADEL ADVISORS LLC | Dispose | 2024-06-30 | 368029 | 2024-09-30 | 118700 | 616053 | -67.74% | 0.03% |
| 2024-11-14 | GRAHAM CAPITAL MANAGEMENT, L.P. | Acquire | 2024-06-30 | 417161 | 2024-09-30 | 426200 | 2211978 | 2.17% | 0.19% |
| 2024-11-14 | FREESTONE CAPITAL HOLDINGS, LLC | Restatement | 2024-03-31 | 18020 | 2024-09-30 | 18020 | 93524 | 0.0% | 0.66% |
| 2024-11-14 | BANK OF AMERICA CORP /DE/ | Acquire | 2024-06-30 | 179951 | 2024-09-30 | 187432 | 972771 | 4.16% | 0.05% |
| 2024-11-14 | POINT72 | Acquire | 2024-09-30 | 1699 | 8818 | 100.0% | 0.07% | ||
| 2024-11-14 | UBS GROUP AG | Acquire | 2024-06-30 | 50773 | 2024-09-30 | 632553 | 3282950 | 1145.85% | 0.16% |
| 2024-11-14 | QUBE RESEARCH & TECHNOLOGIES LTD | Acquire | 2024-09-30 | 1891261 | 9815645 | 100.0% | 1.61% | ||
| 2024-11-14 | PRELUDE CAPITAL MANAGEMENT, LLC | Acquire | 2024-09-30 | 203200 | 1054608 | 100.0% | 1.0% | ||
| 2024-11-14 | TUDOR INVESTMENT CORP ET AL | Acquire | 2024-06-30 | 43219 | 2024-09-30 | 72579 | 376685 | 67.93% | 0.12% |
| 2024-11-14 | BREVAN HOWARD CAPITAL MANAGEMENT LP | Acquire | 2024-06-30 | 39268 | 2024-09-30 | 522716 | 2712897 | 1231.15% | 2.16% |
| 2024-11-14 | XTX TOPCO LTD | Dispose | 2024-06-30 | 69926 | 2024-09-30 | 27381 | 142107 | -60.83% | 0.11% |
| 2024-11-14 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | Dispose | 2024-06-30 | 97324 | 2024-09-30 | 94163 | 488706 | -3.24% | 0.16% |
| 2024-11-14 | ENGINEERS GATE MANAGER LP | Acquire | 2024-09-30 | 48096 | 249618 | 100.0% | 0.21% | ||
| 2024-11-14 | GENEOS WEALTH MANAGEMENT INC. | Acquire | 2024-09-30 | 242 | 1256 | 100.0% | 0.01% | ||
| 2024-11-14 | ROYAL BANK OF CANADA | Acquire | 2024-06-30 | 28442 | 2024-09-30 | 29107 | 151000 | 2.34% | 0.01% |
| 2024-11-14 | WATER ISLAND CAPITAL LLC | Acquire | 2024-09-30 | 2381196 | 12358407 | 100.0% | 13.56% | ||
| 2024-11-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Acquire | 2024-06-30 | 94453 | 2024-09-30 | 96076 | 499000 | 1.72% | 0.02% |
| 2024-11-14 | BARDIN HILL MANAGEMENT PARTNERS LP | Acquire | 2024-09-30 | 100 | 519 | 100.0% | 0.0% | ||
| 2024-11-14 | LEGAL & GENERAL GROUP PLC | Acquire | 2024-06-30 | 71199 | 2024-09-30 | 111628 | 579349 | 56.78% | 0.03% |
| 2024-11-14 | EXOME ASSET MANAGEMENT LLC | Acquire | 2024-09-30 | 347600 | 1804044 | 100.0% | 8.39% | ||
| 2024-11-14 | GLAZER CAPITAL, LLC | Acquire | 2024-09-30 | 3210 | 24900 | 100.0% | 0.01% |
aHolding share amount reported in current period compare to previous period (or compare to the same period if it is an amendment filing). Values can be "Acquire", "Dispose", "Restatement", "Restatement(+)","Restatement(-)". "Restatement(+)/(-)" stands for modification (increase/decrease) to the same period that has been reported before.
b(Current Holding shares - Last or same period holding shares) / Last or same period holding shares x 100%. The value is 100% for records without last period of holding.
cThe percentage of holding value relative to portfolio total.
Note: values subject to change as new filings become available.
COMMON STOCK CSV download realign column header
| Filing Date | Required Datea | Filing Type | Institution | Issuer Name | Aggregate Amount | Pct Shrs Os (%) | Sole Vtg Pow | Shrd Vtg Pow | Sole Dsp Pow | Shrd Dsp Pow | Shared Entityb | Latest 13F Periodc | Latest 13F Holdingd | Operatione | File Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-07 | 2024-09-30 | SC 13G/A | CAPITAL WORLD INVESTORS | REVANCE THERAPEUTICS, INC. | 0 | 0.0 | 0 | 0 | 0 | 0 | 1 | 2024-06-30 | 13938589 | dsp | Link |
| 2024-09-09 | 2024-08-30 | SC 13G/A | CAPITAL WORLD INVESTORS | REVANCE THERAPEUTICS, INC. | 6948769 | 6.6 | 6948769 | 0 | 6948769 | 0 | 1 | 2024-06-30 | 13938589 | dsp | Link |
| 2024-04-09 | 2024-03-29 | SC 13G/A | JPMORGAN CHASE & CO | REVANCE THERAPEUTICS, INC. | 2768691 | 2.6 | 2338930 | 0 | 2756391 | 0 | 1 | 2023-12-31 | 4643419 | dsp | Link |
| 2024-02-14 | 2023-12-31 | SC 13G/A | PALO ALTO INVESTORS LP | REVANCE THERAPEUTICS, INC. | 5237284 | 6.0 | 0 | 5237284 | 0 | 5237284 | 4 | 2023-12-31 | 5237284 | no change | Link |
| 2024-02-14 | 2023-12-31 | SC 13G/A | ANTARA CAPITAL LP | REVANCE THERAPEUTICS, INC. | 0 | 0.0 | 0 | 0 | 0 | 0 | 3 | 2022-12-31 | 6739600 | dsp | Link |
| 2024-02-13 | 2023-12-29 | SC 13G/A | VANGUARD GROUP INC | REVANCE THERAPEUTICS, INC. | 5069625 | 5.8 | 0 | 158028 | 4833890 | 235735 | 1 | 2023-09-30 | 4791459 | acq | Link |
| 2024-02-13 | 2023-12-31 | SC 13G/A | POLAR CAPITAL HOLDINGS PLC | REVANCE THERAPEUTICS, INC. | 3169239 | 3.6 | 3169239 | 0 | 3169239 | 0 | 2 | 2023-12-31 | 3169239 | no change | Link |
| 2024-02-09 | 2023-12-29 | SC 13G/A | CAPITAL WORLD INVESTORS | REVANCE THERAPEUTICS, INC. | 11939076 | 13.6 | 11939076 | 0 | 11939076 | 0 | 1 | 2023-09-30 | 11960820 | dsp | Link |
| 2024-02-06 | 2023-12-31 | SC 13G | FRANKLIN RESOURCES INC | REVANCE THERAPEUTICS, INC. | 6108277 | 6.8 | 0 | 0 | 0 | 0 | 1 | 2023-12-31 | 4749539 | acq | Link |
| 2024-02-06 | 2023-12-31 | SC 13G | FRANKLIN RESOURCES INC | REVANCE THERAPEUTICS, INC. | 6064378 | 6.8 | 6064378 | 0 | 6064378 | 0 | 1 | - | - | - | Link |
| 2024-02-06 | 2023-12-31 | SC 13G | FRANKLIN RESOURCES INC | REVANCE THERAPEUTICS, INC. | 4 | 12.0 | 0 | 0 | 0 | 0 | 2 | - | - | - | Link |
aDate of event which requires filing of this statement.
bThe number of entities that have exactly the same sole/shared voting/disposition power in the same 13G form.
cThe closest 13F filing period on or before the required date.
dThe holding shares reported in the closest 13F filing period on or before the required date.
eThe aggregated amount of shares reported in the 13G filing compare to the holding shares reported in the closest 13F filing (if any).
Note: The latest 13F holding shares and operation (as explained in superscript d and e, respectively) are for reference only, and subject to changes as new 13F filings become available. For a single 13G filing, only the largest aggregated amount is compared with 13F holding shares, others records (if any) are not compared and shown as short dash "-". When no 13F holding records were found, lastest 13F period/holding columns are blank.
Show up to 30 records per table for current tier. Download CSV to view up to 3000 records (Tier 1 and above. Access Guide)